Digital Manufacturing Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035 #1

Driven by the ongoing efforts to overcome the inefficiencies related to manufacturing operations for biologics, the market is likely to present lucrative opportunities for technology providers in coming years.

The global digital manufacturing market size is anticipated to reach at USD 2.0 billion in 2024 to 12.30 billion by 2035, to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period, till 2035.

Currently, batch-to-batch variation and product validation are considered as major bottlenecks faced by the biologic industry. Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics, automation, modelling, process optimization and other digital tools to transform the available information into actionable insights. This is expected to help in the creation of a uniform process, which is capable of decreasing the deviation in quality of each batch. Other key benefits of digital biomanufacturing include improved efficiency, higher product yield, better product quality, data integrity, reduced manual intervention and limited risk of contamination. It is worth noting that digitalization in biopharmaceutical manufacturing is becoming an essential requirement, given its potential to develop enhanced quality products, with high speed, agility and sustainability. Further, digital bioprocessing is believed to have transformed manufacturing principles in areas, such as process development, operational activities, logistics and supply chain management, when used in combination with advanced technologies, including artificial intelligence (AI), machine learning and internet of things (IoT).

The modernization of the biomanufacturing process has been more visible and successful as a result of the recent breakthroughs in the data analytics and data science. Innovative technologies, such as AI and digital twins, have become part of an important strategy for biopharmaceutical companies to future-proof their business operations and address various issues, including growing expenses, stringent regulatory guidelines and deteriorating profit margins. Considering the current market trends and innovation landscape, we anticipate that the next generation of machine learning technologies will be integrated with advanced data analytics, and process and equipment modeling to form comprehensive systems, for the purpose of real-time monitoring and predictive analysis. Further, we believe that, driven by the increasing number of approved biologics, consequent growth in number of biologics-focused clinical trials, rise in R&D activity and rising popularity of cloud and IoT based process technologies, the digital biomanufacturing industry is expected to witness steady growth over the coming years.

Digital biomanufacturing: market landscape
The current market landscape features the presence of over 104 digital biomanufacturing providers offering over 140 different types of platforms, based on PAT, DAS, MES, digital twins. Majority (29) of the companies are located in Europe, followed by those located in North America (20). Notable examples of companies located in Europe include (in alphabetical order) Biopharm, BlueSens, Eppendorf, and Kuhner. It is worth mentioning that majority (45%) of the companies based in Europe are small players, followed by mid-sized firms (28%).

Additional parameters of the Digital Manufacturing Market report:
• The latest research study endows the reader with a comprehensive analysis of the product types of the Digital Manufacturing Market, categorizing the relevant information into the Distribution by Type of Technology (Process Analytical Technology, Data Analysis Software, Manufacturing Execution System and Digital Twin), Deployment Options (Cloud-based and On-premises), Type(s) of Biologic(s) Manufactured (Antibodies, Cell Therapies and Gene Therapies, Proteins, Vaccines, and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa). The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type.

Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Digital Manufacturing Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To request free sample report click on the following link https://www.rootsanalysis.com/reports/digital-biomanufacturing-market/request-sample.html

Driven by the ongoing efforts to overcome the inefficiencies related to manufacturing operations for biologics, the market is likely to present lucrative opportunities for technology providers in coming years. The global [**digital manufacturing market**](https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html) size is anticipated to reach at USD 2.0 billion in 2024 to 12.30 billion by 2035, to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period, till 2035. Currently, batch-to-batch variation and product validation are considered as major bottlenecks faced by the biologic industry. Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics, automation, modelling, process optimization and other digital tools to transform the available information into actionable insights. This is expected to help in the creation of a uniform process, which is capable of decreasing the deviation in quality of each batch. Other key benefits of digital biomanufacturing include improved efficiency, higher product yield, better product quality, data integrity, reduced manual intervention and limited risk of contamination. It is worth noting that digitalization in biopharmaceutical manufacturing is becoming an essential requirement, given its potential to develop enhanced quality products, with high speed, agility and sustainability. Further, digital bioprocessing is believed to have transformed manufacturing principles in areas, such as process development, operational activities, logistics and supply chain management, when used in combination with advanced technologies, including artificial intelligence (AI), machine learning and internet of things (IoT). The modernization of the biomanufacturing process has been more visible and successful as a result of the recent breakthroughs in the data analytics and data science. Innovative technologies, such as AI and digital twins, have become part of an important strategy for biopharmaceutical companies to future-proof their business operations and address various issues, including growing expenses, stringent regulatory guidelines and deteriorating profit margins. Considering the current market trends and innovation landscape, we anticipate that the next generation of machine learning technologies will be integrated with advanced data analytics, and process and equipment modeling to form comprehensive systems, for the purpose of real-time monitoring and predictive analysis. Further, we believe that, driven by the increasing number of approved biologics, consequent growth in number of biologics-focused clinical trials, rise in R&D activity and rising popularity of cloud and IoT based process technologies, the digital biomanufacturing industry is expected to witness steady growth over the coming years. **Digital biomanufacturing: market landscape** The current market landscape features the presence of over 104 digital biomanufacturing providers offering over 140 different types of platforms, based on PAT, DAS, MES, digital twins. Majority (29) of the companies are located in Europe, followed by those located in North America (20). Notable examples of companies located in Europe include (in alphabetical order) Biopharm, BlueSens, Eppendorf, and Kuhner. It is worth mentioning that majority (45%) of the companies based in Europe are small players, followed by mid-sized firms (28%). **Additional parameters of the Digital Manufacturing Market report:** • The latest research study endows the reader with a comprehensive analysis of the product types of the Digital Manufacturing Market, categorizing the relevant information into the Distribution by Type of Technology (Process Analytical Technology, Data Analysis Software, Manufacturing Execution System and Digital Twin), Deployment Options (Cloud-based and On-premises), Type(s) of Biologic(s) Manufactured (Antibodies, Cell Therapies and Gene Therapies, Proteins, Vaccines, and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa). The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. **Research Methodology** Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Digital Manufacturing Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. **To request free sample report click on the following link** https://www.rootsanalysis.com/reports/digital-biomanufacturing-market/request-sample.html

roots-analysis-logo(200 by 200) (1).png

42 KiB